Urinary Tract Infection Testing Market Expands Across APAC, Europe, USA, and Saudi Arabia with Strong Growth Outlook to 2035

The Urinary Tract Infection Testing Market is experiencing robust growth as the global burden of UTIs continues to increase, particularly among women, elderly individuals, and patients with chronic illnesses. Valued at USD 5.47 billion in 2025, the market is projected to reach USD 9.98 billion by 2035, expanding at a CAGR of 6.2%.

Rapid advancements in testing technologies, such as point-of-care and home diagnostic kits, are reshaping accessibility and improving early detection outcomes. Hospital laboratories currently account for 54.7% of the testing volume due to high diagnostic capacity and the need for antimicrobial resistance evaluation.

Explore trends before investing – request a sample report today!

https://www.futuremarketinsights.com/reports/sample/rep-gb-10134

Innovation Accelerates Diagnostic Speed and Accuracy

One significant industry milestone occurred in June 2024, when Sysmex Astrego secured the £8 million Longitude Prize for its PA-100 AST System. The system reduces diagnostic time to approximately 45 minutes, compared to the traditional multi-day culture process. This demonstrates the sector's shift toward rapid, decentralized testing to manage antibiotic resistance more effectively.

In parallel, telehealth-integrated home UTI testing kits—such as Winx Health’s "Test + Treat" platform—are making diagnostic support accessible outside clinical environments. This supports better patient compliance and reduces unnecessary hospital visits.

Regional Market Highlights: APAC, Europe, USA, Saudi Arabia

United States

The U.S. market remains a leading contributor, supported by strong healthcare infrastructure, insurance coverage, and an aging population susceptible to UTIs. Increased adoption of rapid, point-of-care diagnostic solutions is further driving market penetration.

Europe

Germany, the UK, and France are key contributors, with strong preventive healthcare frameworks. Hospitals in these markets are adopting automated urinalysis platforms that enhance precision and reporting efficiency.

Asia-Pacific

APAC markets, particularly India and Japan, are expanding rapidly due to improved diagnostic access, government health campaigns, and greater awareness of antimicrobial stewardship. India is projected to be among the fastest-growing markets with significant adoption of PCR-based testing.

Saudi Arabia

Growing investments in hospital infrastructure, national infectious disease management programs, and digital health integration are supporting strong market growth in Saudi Arabia. Increasing expatriate population and rising lifestyle-related UTI prevalence further contribute to demand.

Urinalysis Segment Drives Market Growth

The urinalysis segment is expected to hold 63.4% market share in 2025, reinforced by its affordability, rapid turnaround, and widespread use in hospitals and outpatient clinics. Innovations in digital microscopy and automated analyzers are enhancing diagnostic accuracy and reducing processing time.

Hospital Laboratories Remain Central to Testing Services

Holding 54.7% of the end-user market share, hospital laboratories continue to lead due to their high testing capacity and the necessity of antimicrobial susceptibility testing. Integration with laboratory information systems ensures efficient diagnostic workflows and treatment planning.

Competitive Landscape

The market is moderately concentrated, with leading players including Roche, Siemens Healthineers, Danaher, Thermo Fisher Scientific, Sysmex Corporation, and Abbott. These companies are investing in automation, molecular diagnostics, and decentralized testing technologies to enhance clinical outcomes.

Buy Report Now – Click Here to Purchase the Report:

https://www.futuremarketinsights.com/checkout/10134

Latest In-vitro Diagnostics Devices Reports:

SpO2 Medical Cable Market

https://www.futuremarketinsights.com/reports/spo2-medical-cable-market

DNA Diagnostics Market

https://www.futuremarketinsights.com/reports/dna-diagnostics-market

Exosomes Diagnostic and Therapeutic Market

https://www.futuremarketinsights.com/reports/exosome-diagnostic-and-therapeutics-market

Why Choose FMI – Empowering Decisions that Drive Real-World Outcomes:

https://www.futuremarketinsights.com/why-fmi

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs | YouTube